nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—Anaemia megaloblastic—Azathioprine—systemic scleroderma	0.0583	0.0583	CcSEcCtD
Pentobarbital—Anaemia megaloblastic—Methotrexate—systemic scleroderma	0.0235	0.0235	CcSEcCtD
Pentobarbital—Liver injury—Captopril—systemic scleroderma	0.0187	0.0187	CcSEcCtD
Pentobarbital—Liver injury—Azathioprine—systemic scleroderma	0.0163	0.0163	CcSEcCtD
Pentobarbital—Hepatocellular injury—Captopril—systemic scleroderma	0.0157	0.0157	CcSEcCtD
Pentobarbital—Liver injury—Leflunomide—systemic scleroderma	0.0154	0.0154	CcSEcCtD
Pentobarbital—Liver injury—Mycophenolic acid—systemic scleroderma	0.0147	0.0147	CcSEcCtD
Pentobarbital—Apnoea—Mycophenolic acid—systemic scleroderma	0.0146	0.0146	CcSEcCtD
Pentobarbital—Hepatocellular injury—Azathioprine—systemic scleroderma	0.0137	0.0137	CcSEcCtD
Pentobarbital—Hepatocellular injury—Leflunomide—systemic scleroderma	0.013	0.013	CcSEcCtD
Pentobarbital—Respiratory failure—Mycophenolic acid—systemic scleroderma	0.0126	0.0126	CcSEcCtD
Pentobarbital—Hepatocellular injury—Mycophenolic acid—systemic scleroderma	0.0124	0.0124	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Captopril—systemic scleroderma	0.0121	0.0121	CcSEcCtD
Pentobarbital—Liver injury—Mycophenolate mofetil—systemic scleroderma	0.0116	0.0116	CcSEcCtD
Pentobarbital—Apnoea—Mycophenolate mofetil—systemic scleroderma	0.0115	0.0115	CcSEcCtD
Pentobarbital—Ataxia—Captopril—systemic scleroderma	0.0107	0.0107	CcSEcCtD
Pentobarbital—Respiratory failure—Mycophenolate mofetil—systemic scleroderma	0.00995	0.00995	CcSEcCtD
Pentobarbital—Hepatocellular injury—Mycophenolate mofetil—systemic scleroderma	0.00977	0.00977	CcSEcCtD
Pentobarbital—Injection site reaction—Mycophenolate mofetil—systemic scleroderma	0.00971	0.00971	CcSEcCtD
Pentobarbital—Tension—Pentoxifylline—systemic scleroderma	0.00891	0.00891	CcSEcCtD
Pentobarbital—Nervousness—Pentoxifylline—systemic scleroderma	0.00882	0.00882	CcSEcCtD
Pentobarbital—Hypoxia—Methotrexate—systemic scleroderma	0.00871	0.00871	CcSEcCtD
Pentobarbital—Hyperkinesia—Mycophenolate mofetil—systemic scleroderma	0.00852	0.00852	CcSEcCtD
Pentobarbital—Ataxia—Mycophenolic acid—systemic scleroderma	0.00845	0.00845	CcSEcCtD
Pentobarbital—Agitation—Pentoxifylline—systemic scleroderma	0.00835	0.00835	CcSEcCtD
Pentobarbital—Angioedema—Pentoxifylline—systemic scleroderma	0.0083	0.0083	CcSEcCtD
Pentobarbital—Hallucination—Captopril—systemic scleroderma	0.00787	0.00787	CcSEcCtD
Pentobarbital—Anxiety—Pentoxifylline—systemic scleroderma	0.00771	0.00771	CcSEcCtD
Pentobarbital—Ataxia—Lisinopril—systemic scleroderma	0.00761	0.00761	CcSEcCtD
Pentobarbital—Confusional state—Pentoxifylline—systemic scleroderma	0.00747	0.00747	CcSEcCtD
Pentobarbital—Shock—Pentoxifylline—systemic scleroderma	0.00729	0.00729	CcSEcCtD
Pentobarbital—Angioedema—Mometasone—systemic scleroderma	0.00716	0.00716	CcSEcCtD
Pentobarbital—Hypotension—Pentoxifylline—systemic scleroderma	0.00693	0.00693	CcSEcCtD
Pentobarbital—Tension—Captopril—systemic scleroderma	0.00675	0.00675	CcSEcCtD
Pentobarbital—Nervousness—Captopril—systemic scleroderma	0.00668	0.00668	CcSEcCtD
Pentobarbital—Somnolence—Pentoxifylline—systemic scleroderma	0.00659	0.00659	CcSEcCtD
Pentobarbital—Apnoea—Methotrexate—systemic scleroderma	0.00653	0.00653	CcSEcCtD
Pentobarbital—Constipation—Pentoxifylline—systemic scleroderma	0.00634	0.00634	CcSEcCtD
Pentobarbital—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00633	0.00633	CcSEcCtD
Pentobarbital—Angioedema—Captopril—systemic scleroderma	0.00629	0.00629	CcSEcCtD
Pentobarbital—Hallucination—Mycophenolic acid—systemic scleroderma	0.00619	0.00619	CcSEcCtD
Pentobarbital—Syncope—Captopril—systemic scleroderma	0.00617	0.00617	CcSEcCtD
Pentobarbital—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00611	0.00611	CcSEcCtD
Pentobarbital—Loss of consciousness—Captopril—systemic scleroderma	0.00605	0.00605	CcSEcCtD
Pentobarbital—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00586	0.00586	CcSEcCtD
Pentobarbital—Hyperkinesia—Prednisone—systemic scleroderma	0.00578	0.00578	CcSEcCtD
Pentobarbital—Bradycardia—Lisinopril—systemic scleroderma	0.0057	0.0057	CcSEcCtD
Pentobarbital—Confusional state—Captopril—systemic scleroderma	0.00566	0.00566	CcSEcCtD
Pentobarbital—Respiratory failure—Methotrexate—systemic scleroderma	0.00564	0.00564	CcSEcCtD
Pentobarbital—Hallucination—Lisinopril—systemic scleroderma	0.00557	0.00557	CcSEcCtD
Pentobarbital—Shock—Captopril—systemic scleroderma	0.00553	0.00553	CcSEcCtD
Pentobarbital—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00546	0.00546	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Methotrexate—systemic scleroderma	0.00534	0.00534	CcSEcCtD
Pentobarbital—Tension—Mycophenolic acid—systemic scleroderma	0.00531	0.00531	CcSEcCtD
Pentobarbital—Nervousness—Mycophenolic acid—systemic scleroderma	0.00526	0.00526	CcSEcCtD
Pentobarbital—Hypotension—Captopril—systemic scleroderma	0.00525	0.00525	CcSEcCtD
Pentobarbital—Angioedema—Leflunomide—systemic scleroderma	0.00518	0.00518	CcSEcCtD
Pentobarbital—Body temperature increased—Mometasone—systemic scleroderma	0.00506	0.00506	CcSEcCtD
Pentobarbital—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00499	0.00499	CcSEcCtD
Pentobarbital—Somnolence—Captopril—systemic scleroderma	0.00499	0.00499	CcSEcCtD
Pentobarbital—Agitation—Mycophenolic acid—systemic scleroderma	0.00497	0.00497	CcSEcCtD
Pentobarbital—Dizziness—Pentoxifylline—systemic scleroderma	0.0049	0.0049	CcSEcCtD
Pentobarbital—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00488	0.00488	CcSEcCtD
Pentobarbital—Syncope—Mycophenolic acid—systemic scleroderma	0.00485	0.00485	CcSEcCtD
Pentobarbital—Anxiety—Leflunomide—systemic scleroderma	0.00481	0.00481	CcSEcCtD
Pentobarbital—Constipation—Captopril—systemic scleroderma	0.0048	0.0048	CcSEcCtD
Pentobarbital—Tension—Lisinopril—systemic scleroderma	0.00478	0.00478	CcSEcCtD
Pentobarbital—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00476	0.00476	CcSEcCtD
Pentobarbital—Nervousness—Lisinopril—systemic scleroderma	0.00473	0.00473	CcSEcCtD
Pentobarbital—Vomiting—Pentoxifylline—systemic scleroderma	0.00471	0.00471	CcSEcCtD
Pentobarbital—Rash—Pentoxifylline—systemic scleroderma	0.00467	0.00467	CcSEcCtD
Pentobarbital—Dermatitis—Pentoxifylline—systemic scleroderma	0.00467	0.00467	CcSEcCtD
Pentobarbital—Headache—Pentoxifylline—systemic scleroderma	0.00464	0.00464	CcSEcCtD
Pentobarbital—Feeling abnormal—Captopril—systemic scleroderma	0.00463	0.00463	CcSEcCtD
Pentobarbital—Anxiety—Mycophenolic acid—systemic scleroderma	0.00459	0.00459	CcSEcCtD
Pentobarbital—Hypotension—Azathioprine—systemic scleroderma	0.00458	0.00458	CcSEcCtD
Pentobarbital—Angioedema—Lisinopril—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Pentobarbital—Confusional state—Mycophenolic acid—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Pentobarbital—Body temperature increased—Captopril—systemic scleroderma	0.00444	0.00444	CcSEcCtD
Pentobarbital—Nausea—Pentoxifylline—systemic scleroderma	0.0044	0.0044	CcSEcCtD
Pentobarbital—Syncope—Lisinopril—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Pentobarbital—Shock—Mycophenolic acid—systemic scleroderma	0.00435	0.00435	CcSEcCtD
Pentobarbital—Hypotension—Leflunomide—systemic scleroderma	0.00433	0.00433	CcSEcCtD
Pentobarbital—Loss of consciousness—Lisinopril—systemic scleroderma	0.00428	0.00428	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00426	0.00426	CcSEcCtD
Pentobarbital—Tension—Mycophenolate mofetil—systemic scleroderma	0.00419	0.00419	CcSEcCtD
Pentobarbital—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00415	0.00415	CcSEcCtD
Pentobarbital—Anxiety—Lisinopril—systemic scleroderma	0.00414	0.00414	CcSEcCtD
Pentobarbital—Hypotension—Mycophenolic acid—systemic scleroderma	0.00413	0.00413	CcSEcCtD
Pentobarbital—Vomiting—Mometasone—systemic scleroderma	0.00407	0.00407	CcSEcCtD
Pentobarbital—Feeling abnormal—Azathioprine—systemic scleroderma	0.00404	0.00404	CcSEcCtD
Pentobarbital—Rash—Mometasone—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Pentobarbital—Dermatitis—Mometasone—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Pentobarbital—Confusional state—Lisinopril—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Pentobarbital—Headache—Mometasone—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Pentobarbital—Constipation—Leflunomide—systemic scleroderma	0.00396	0.00396	CcSEcCtD
Pentobarbital—Somnolence—Mycophenolic acid—systemic scleroderma	0.00393	0.00393	CcSEcCtD
Pentobarbital—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Pentobarbital—Shock—Lisinopril—systemic scleroderma	0.00391	0.00391	CcSEcCtD
Pentobarbital—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.0039	0.0039	CcSEcCtD
Pentobarbital—Body temperature increased—Azathioprine—systemic scleroderma	0.00388	0.00388	CcSEcCtD
Pentobarbital—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00383	0.00383	CcSEcCtD
Pentobarbital—Feeling abnormal—Leflunomide—systemic scleroderma	0.00381	0.00381	CcSEcCtD
Pentobarbital—Nausea—Mometasone—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Pentobarbital—Ataxia—Methotrexate—systemic scleroderma	0.00378	0.00378	CcSEcCtD
Pentobarbital—Constipation—Mycophenolic acid—systemic scleroderma	0.00378	0.00378	CcSEcCtD
Pentobarbital—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00375	0.00375	CcSEcCtD
Pentobarbital—Hypotension—Lisinopril—systemic scleroderma	0.00372	0.00372	CcSEcCtD
Pentobarbital—Dizziness—Captopril—systemic scleroderma	0.00371	0.00371	CcSEcCtD
Pentobarbital—Body temperature increased—Leflunomide—systemic scleroderma	0.00366	0.00366	CcSEcCtD
Pentobarbital—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00364	0.00364	CcSEcCtD
Pentobarbital—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00362	0.00362	CcSEcCtD
Pentobarbital—Hypersensitivity—Azathioprine—systemic scleroderma	0.00361	0.00361	CcSEcCtD
Pentobarbital—Vomiting—Captopril—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Pentobarbital—Rash—Captopril—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Pentobarbital—Dermatitis—Captopril—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Pentobarbital—Somnolence—Lisinopril—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Pentobarbital—Headache—Captopril—systemic scleroderma	0.00352	0.00352	CcSEcCtD
Pentobarbital—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Pentobarbital—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Pentobarbital—Shock—Mycophenolate mofetil—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Pentobarbital—Hypersensitivity—Leflunomide—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Pentobarbital—Constipation—Lisinopril—systemic scleroderma	0.0034	0.0034	CcSEcCtD
Pentobarbital—Bradycardia—Prednisone—systemic scleroderma	0.00339	0.00339	CcSEcCtD
Pentobarbital—Nausea—Captopril—systemic scleroderma	0.00334	0.00334	CcSEcCtD
Pentobarbital—Hallucination—Prednisone—systemic scleroderma	0.00331	0.00331	CcSEcCtD
Pentobarbital—Feeling abnormal—Lisinopril—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Pentobarbital—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00326	0.00326	CcSEcCtD
Pentobarbital—Dizziness—Azathioprine—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Pentobarbital—Body temperature increased—Lisinopril—systemic scleroderma	0.00314	0.00314	CcSEcCtD
Pentobarbital—Vomiting—Azathioprine—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Pentobarbital—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Pentobarbital—Rash—Azathioprine—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Pentobarbital—Dermatitis—Azathioprine—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Pentobarbital—Headache—Azathioprine—systemic scleroderma	0.00307	0.00307	CcSEcCtD
Pentobarbital—Dizziness—Leflunomide—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Pentobarbital—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Pentobarbital—Vomiting—Leflunomide—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Pentobarbital—Hypersensitivity—Lisinopril—systemic scleroderma	0.00293	0.00293	CcSEcCtD
Pentobarbital—Dizziness—Mycophenolic acid—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Pentobarbital—Rash—Leflunomide—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Pentobarbital—Dermatitis—Leflunomide—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Pentobarbital—Nausea—Azathioprine—systemic scleroderma	0.00291	0.00291	CcSEcCtD
Pentobarbital—Headache—Leflunomide—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Pentobarbital—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Pentobarbital—Vomiting—Mycophenolic acid—systemic scleroderma	0.00281	0.00281	CcSEcCtD
Pentobarbital—Rash—Mycophenolic acid—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Pentobarbital—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Pentobarbital—Headache—Mycophenolic acid—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Pentobarbital—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Pentobarbital—Nausea—Leflunomide—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Pentobarbital—Agitation—Prednisone—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Pentobarbital—Angioedema—Prednisone—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Pentobarbital—Dizziness—Lisinopril—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Pentobarbital—Nausea—Mycophenolic acid—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Pentobarbital—Syncope—Prednisone—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Pentobarbital—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Pentobarbital—Loss of consciousness—Prednisone—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Pentobarbital—Vomiting—Lisinopril—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Pentobarbital—Rash—Lisinopril—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Pentobarbital—Dermatitis—Lisinopril—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Pentobarbital—Headache—Lisinopril—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Pentobarbital—Anxiety—Prednisone—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Pentobarbital—Nausea—Lisinopril—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Pentobarbital—Shock—Prednisone—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Pentobarbital—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Pentobarbital—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Pentobarbital—Rash—Mycophenolate mofetil—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Pentobarbital—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Pentobarbital—Headache—Mycophenolate mofetil—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Pentobarbital—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Pentobarbital—Constipation—Prednisone—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Pentobarbital—Confusional state—Methotrexate—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Pentobarbital—Feeling abnormal—Prednisone—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Pentobarbital—Body temperature increased—Prednisone—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Pentobarbital—Hypotension—Methotrexate—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Pentobarbital—Somnolence—Methotrexate—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Pentobarbital—Hypersensitivity—Prednisone—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Pentobarbital—Feeling abnormal—Methotrexate—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Pentobarbital—Dizziness—Prednisone—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Pentobarbital—Body temperature increased—Methotrexate—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Pentobarbital—Vomiting—Prednisone—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Pentobarbital—Rash—Prednisone—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Pentobarbital—Dermatitis—Prednisone—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Pentobarbital—Headache—Prednisone—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Pentobarbital—Hypersensitivity—Methotrexate—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Pentobarbital—Nausea—Prednisone—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Pentobarbital—Dizziness—Methotrexate—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Pentobarbital—Vomiting—Methotrexate—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Pentobarbital—Rash—Methotrexate—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Pentobarbital—Dermatitis—Methotrexate—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Pentobarbital—Headache—Methotrexate—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Pentobarbital—Nausea—Methotrexate—systemic scleroderma	0.00117	0.00117	CcSEcCtD
